-
Rules for Classification of Medical Devices
2019-10-11
The Rules for Classification of Medical Devices, adopted at the executive meeting of China Food and Drug Administration on June 3, 2015, is hereby promulgated and shall be effective as of January 1, 2016.
-
Provisions for Instructions and Labels of Medical Devices (Decree No.6 of China Food and Drug Administration)
2019-10-11
The Provisions for Instructions and Labels of Medical Devices, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.
-
Provisions for Drug Recall (SFDA Decree No. 29) (Abolished)
2019-10-11
The Provisions for Drug Recall was deliberated and adopted by the executive meeting of the State Food and Drug Administration on December 6, 2007 and now is issued. These Provisions shall go into effect as of the date of promulgation.
-
Provisions for the Lot Release of Biological Products (CFDA Decree No.39) (Abolished)
2019-10-11
Provisions for the Lot Release of Biological Products, deliberated and adopted at the executive meeting of China Food and Drug Administration on December 20, 2017, is hereby promulgated and shall go into effect as of February 1, 2018.
-
Decree of State Food and Drug Administration
2019-10-10
The Provisions for Drug Importation, adopted by the State Food and Drug Administration and the General Administration of Customs of the People's Republic of China, is hereby promulgated and shall go into effect as of January 1, 2004.
-
Drug Administration Law of the People's Republic of China
2019-09-26
(Adopted at the 7th Meeting of the Standing Committee of the Sixth National People's Congress on September 20, 1984; revised for the first time at the 20th Meeting of the Standing Committee of the Ninth National People's Congress on February 28, 2001; amended for the first time in accordance with the Decision on Revising Seven Laws Including the Marine Environmental Protection Law of the People's Republic of China adopted at the 6th Meeting of the Standing Committee of the Twelfth National People's Congress on December 28, 2013; amended for the second time in accordance with the Decision on Revising the Drug Administration Law of the People's Republic of China adopted at the 14th Meeting of the Standing Committee of the Twelfth National People's Congress on April 24, 2015; revised for the second time at the 12th Meeting of the Standing Committee of the Thirteenth National People's Congress on August 26, 2019)
